Brief: Zelira Therapeutics Seeks Trading Halt
12/02/2023 22:26
Feb 13 (Reuters) - Zelira Therapeutics Ltd ZLD.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CLINICAL TRIAL
FUNDING
Source text for Eikon: ID:nASX7p9dhG
Further company coverage: ZLD.AX
Recent news on Zelira Therapeutics
See all newsBrief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
Australia's Zelira Therapeutics surges on $33 million funding for drug trial
Australia's Zelira Therapeutics climbs to over 7-month high on securing patents
Brief: Zelira Therapeutics Receives USD$1.4 Million Unsecured Loan Funds From Chairman
Brief: Zelira Therapeutics Ltd Says Zld Secures Us$1.4M Unsecured Chairman Loan Facility